Acetylcholinesterase Inhibitors & Skeletal Muscle: From Twitching to Paralysis

Acetylcholinesterase (AChE) rapidly hydrolyzes acetylcholine (ACh) at the neuromuscular junction (NMJ), terminating muscle contraction. Inhibiting AChE (by organophosphates, nerve agents, or drugs like neostigmine) prolongs ACh action, causing a cascade of effects:

  1. Enhanced & prolonged contraction – Excess ACh causes repetitive depolarization, stronger initial contractions.
  2. Cholinergic crisis – Sustained ACh accumulation leads to continuous stimulation without relaxation: fasciculations (twitching), muscle weakness, fatigue.
  3. Depolarization blockade – Persistent depolarization inactivates voltage-gated Na⁺ channels, causing flaccid paralysis (including respiratory muscles).
  4. Respiratory failure – Paralysis of diaphragm/intercostals is life-threatening; requires mechanical ventilation.
  5. Neurotoxic effects – Chronic inhibition can damage motor neurons and muscle fibers, causing long-term weakness.

Clinical Context

  • Reversible inhibitors (pyridostigmine, neostigmine) treat myasthenia gravis; dose titration avoids crisis.
  • Irreversible inhibitors (organophosphate pesticides, sarin, VX) cause acute poisoning; treated with atropine + oximes (pralidoxime) + benzodiazepines for seizures.

Normal AChE function is essential for precise, phasic muscle control.

Muscle Strains - Related Articles